These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 22718393)

  • 21. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY; Wang QL; Shen L; Fu WW; Liu CH
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
    Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
    Mou S; Wang Q; Shi B; Gu L; Ni Z
    Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neferine inhibits cultured hepatic stellate cell activation and facilitates apoptosis: A possible molecular mechanism.
    Ding H; Shi J; Wang Y; Guo J; Zhao J; Dong L
    Eur J Pharmacol; 2011 Jan; 650(1):163-9. PubMed ID: 20969858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
    Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
    Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
    Stolz DB; Michalopoulos GK
    J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
    J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.
    Venkatraman L; Chia SM; Narmada BC; White JK; Bhowmick SS; Forbes Dewey C; So PT; Tucker-Kellogg L; Yu H
    Biophys J; 2012 Sep; 103(5):1060-8. PubMed ID: 23009856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.
    Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
    Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats.
    Bai G; Yan G; Wang G; Wan P; Zhang R
    Oncol Rep; 2016 Nov; 36(5):2902-2910. PubMed ID: 27633729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells.
    Shimada H; Staten NR; Rajagopalan LE
    J Hepatol; 2011 Mar; 54(3):521-8. PubMed ID: 21087804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor.
    Michalopoulos GK; Bowen WC; Zajac VF; Beer-Stolz D; Watkins S; Kostrubsky V; Strom SC
    Hepatology; 1999 Jan; 29(1):90-100. PubMed ID: 9862855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
    Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
    J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells.
    Liu J; Gong H; Zhang ZT; Wang Y
    Chin Med J (Engl); 2008 Jan; 121(2):161-5. PubMed ID: 18272044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-β1.
    Leilei L; Xue S; Yan L; Yuyuan L; Ying W; Wenke Q; Xuesong Y; Ming L
    Biochem Biophys Res Commun; 2021 Sep; 569():125-131. PubMed ID: 34243068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
    Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
    J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.